Santarsiere Rita, Florio Giulia, Gonnella Annalisa, D'Angiò Pierluigi, Laurino Simona, Zacchia Miriam, Del Vecchio Blanco Francesca, Perna Alessandra F, Trepiccione Francesco, Gigliotti Giuseppe
Department of Medical Translational Sciences, University of Campania "L. Vanvitelli", Naples, Italy.
Department of Medical Translational Sciences, University of Campania "L. Vanvitelli", Naples, Italy,
Kidney Blood Press Res. 2025;50(1):429-432. doi: 10.1159/000546321. Epub 2025 May 23.
CFHR5 nephropathy is considered a subtype of C3 glomerulopathy. It was originally described in Greek Cypriot families and it is characterized by the time with the development of microscopic hematuria and proteinuria associated with a fast progression toward ESKD, especially in men. These symptoms present an autosomal dominant inheritance pattern and are associated with the exon 2 to 3 duplication of the CFHR5 gene.
Here, we describe a novel clinical phenotype associated with a variant of the CFHR5. The affected subjects present the clinical features of autosomal dominant tubulo-interstitial kidney disease. They present with CKD of unknown origin with no hematuria nor proteinuria. Like the classical CFHR5 nephropathy, males have a worse prognosis than females, with a fast progression toward ESKD in the second-third decade of life. Kidney pathology shows severe tubular atrophy and interstitial fibrosis and infiltrate. Arteries involvement is characterized by thickening of the intima layer, while no major alterations are described at the glomerular level. Electron microscopy confirms no interstitial or glomerular filtration barrier alterations.
The exact mechanism behind this phenomenon remains unclear; we hope that our case will encourage further investigation.
CFHR5肾病被认为是C3肾小球病的一种亚型。它最初在希腊裔塞浦路斯家族中被描述,其特征是出现镜下血尿和蛋白尿,并快速进展至终末期肾病(ESKD),尤其是男性。这些症状呈现常染色体显性遗传模式,且与CFHR5基因外显子2至3重复有关。
在此,我们描述了一种与CFHR5变异相关的新型临床表型。受影响的受试者呈现常染色体显性肾小管间质性肾病的临床特征。他们表现为不明原因的慢性肾脏病,无血尿和蛋白尿。与经典的CFHR5肾病一样,男性预后比女性差,在生命的第二个三十年快速进展至ESKD。肾脏病理学显示严重的肾小管萎缩、间质纤维化和浸润。动脉受累表现为内膜层增厚,而肾小球水平未描述有重大改变。电子显微镜证实无间质或肾小球滤过屏障改变。
这一现象背后的确切机制仍不清楚;我们希望我们的病例能鼓励进一步的研究。